Intelligent Bio Solutions starts interference study for FDA drug screening submission

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. HOOD
7. DFTX
8. GOOGL
9. MU
10. IBM

Go back to Intelligent Bio Solutions starts interference study for FDA drug screening submission
(NASDAQ: INBS) Delayed: 2.38 +0.09 (3.93%)
Previous Close $2.29    52 Week High $ 
Open $2.35    52 Week Low $ 
Day High $2.40    P/E N/A 
Day Low $2.33    EPS $ 
Volume 18,933